News
around the biocity campus

News

Bioengineered livers mimic natural development

An international team of researchers from the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, Cincinnati Children’s Hospital Medical Center, USA, and Yokohama City University, Japan, used novel genomic and stem cell technologies to understand how individual cells work together and use their genomes to develop into human liver tissue. This new research greatly advances efforts to bioengineer healthy and usable human liver tissue from human pluripotent stem cells.
more

BIO CITY LEIPZIG rated under the 15 Best Biotech Incubators in Europe

We proudly announce BIO CITY LEIPZIG beeing rated under the top 15 biotech incubators in Europe by labiotech.eu
more

c-LEcta’s Enzyme enabled a novel enzyme cascade – the synthesis of biopolymer precursors

The economic synthesis of valuable compounds by multi enzymatic transformations is gaining more and more attention. This is because the combination of different enzyme activities can make novel, economic synthetic routes accessible and may drive reversible reaction to completion.
more

150,000 stem cell deposits at Vita 34

Vita 34 on the BioCity Campus Leipzig celebrates the 150000th stem cell storage and the 20th company anniversary with an international expert symposium on the application of stem cells in children. With 150,000 stem cell deposits from 29 countries in Europe and worldwide as well as 30 applications, Vita 34 is the largest and most experienced stem cell bank in the German-speaking countries.
more

c-LEcta Extended its Biodiversity Platform by Genomic Libraries from Marine Sources

To meet the demand of new enzymes for industrial applications c-LEcta has extended its biodiversity platform by Genomic libraries from marine sources. New and innovative process technologies in industry demand highly advanced enzymes that can cope with harsh reaction conditions while simultaneously offering highest performance. The analysis of natural biodiversity provides a practically unlimited source for identification of such new enzymatic activities as well as bioactive compounds.
more

iDiv: Carnivores more seriously threatened by roads than previously acknowledged

The effects of roads on carnivores have obviously been underestimated in worldwide species conservation. This is the conclusion of the first comprehensive global study on this topic, which has been published in the scientific journal “Global Ecology and Biogeography” by an international research team from Germany and Portugal. The protection status of several species that are severely affected by roads cut through their habitat should be reconsidered, the researchers say.
more

Fraunhofer IZI and Immunic GmbH carry out joint research on new drugs for treating autoimmune diseases

Fraunhofer IZI. Since January 2017, researchers from Immunic GmbH have been working with scientists at the Department of Drug Design and Target Validation of the Fraunhofer IZI in Halle (Saale) on developing new drugs. The aim is the preclinical development of one or several active candidate ingredients for treating chronically inflammatory and autoimmune diseases.
more

c-LEcta starts Marketing & Distribution of DENARASE®

DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.
more